18,616 followers
Benefits of switching from intravenous to subcutaneous daratumumab: Perspectives from UK healthcare providers https://t.co/TROFreH9m4 https://t.co/v7zCZN0B59
Benefits of switching from intravenous to subcutaneous daratumumab: Perspectives from UK healthcare providers https://t.co/TROFreH9m4 https://t.co/v7zCZN0B59
New research: Benefits of switching from intravenous to subcutaneous daratumumab: Perspectives from UK healthcare providers: Daratumumab is a CD38-directed monoclonal antibody indicated to treat multiple myeloma (MM). Daratumumab was initially… https://t.c